Literature DB >> 36119193

Recurrent hiccups in COVID-19 forme fruste of neuromyelitis optica spectrum disorder?

Khichar P Shubhakaran1.   

Abstract

Entities:  

Year:  2022        PMID: 36119193      PMCID: PMC9480737          DOI: 10.4103/jfmpc.jfmpc_551_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


× No keyword cloud information.
  5 in total

1.  Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.

Authors:  T Misu; K Fujihara; I Nakashima; S Sato; Y Itoyama
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

2.  Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

Authors:  Elena Sherman; May H Han
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

3.  Hiccups and hyponatremia: Unusual co-presentation in COVID-19.

Authors:  Samarth Sangamesh; Siddharth Gosavi; Shashank Shastry; Sandra M Johny
Journal:  J Family Med Prim Care       Date:  2021-02-27

4.  A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City.

Authors:  Jennifer A Frontera; Sakinah Sabadia; Rebecca Lalchan; Taolin Fang; Brent Flusty; Patricio Millar-Vernetti; Thomas Snyder; Stephen Berger; Dixon Yang; Andre Granger; Nicole Morgan; Palak Patel; Josef Gutman; Kara Melmed; Shashank Agarwal; Matthew Bokhari; Andres Andino; Eduard Valdes; Mirza Omari; Alexandra Kvernland; Kaitlyn Lillemoe; Sherry H-Y Chou; Molly McNett; Raimund Helbok; Shraddha Mainali; Ericka L Fink; Courtney Robertson; Michelle Schober; Jose I Suarez; Wendy Ziai; David Menon; Daniel Friedman; David Friedman; Manisha Holmes; Joshua Huang; Sujata Thawani; Jonathan Howard; Nada Abou-Fayssal; Penina Krieger; Ariane Lewis; Aaron S Lord; Ting Zhou; D Ethan Kahn; Barry M Czeisler; Jose Torres; Shadi Yaghi; Koto Ishida; Erica Scher; Adam de Havenon; Dimitris Placantonakis; Mengling Liu; Thomas Wisniewski; Andrea B Troxel; Laura Balcer; Steven Galetta
Journal:  Neurology       Date:  2020-10-05       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.